Antitumor and anti-angiogenesis immunity induced by CR-SEREX-identified Xenopus RHAMM

Cancer Science

Volumn 101, Issue 4, 2010, Pages 862-868

  Yang, Han Shuo ^a   Zhang, Dong Mei ^a   Deng, Hong Xin ^a   Peng, Feng ^a   Wei, Yu Quan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CANCER VACCINE; DNA VACCINE; HYALURONIC ACID MEDIATED MOTILITY RECEPTOR; UNCLASSIFIED DRUG; HERMES ANTIGEN; HETEROPHILE ANTIGEN;

ADAPTIVE IMMUNITY; ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTIBODY PRODUCTION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER IMMUNIZATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS REACTION; CROSS REACTIVE SEROLOGICAL EXPRESSION CLONING; CYTOTOXIC T LYMPHOCYTE; DRUG EFFICACY; DRUG MECHANISM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; LUNG METASTASIS; MELANOMA B16; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; T CELL DEPLETION; T LYMPHOCYTE SUBPOPULATION; XENOPUS; ANIMAL; EXPERIMENTAL MELANOMA; GENETICS; IMMUNOLOGY; NEOVASCULARIZATION (PATHOLOGY); VASCULARIZATION; XENOPUS LAEVIS;

ANIMALS; ANTIGENS, CD44; ANTIGENS, HETEROPHILE; CANCER VACCINES; CLONING, MOLECULAR; CROSS REACTIONS; IMMUNITY, CELLULAR; MELANOMA, EXPERIMENTAL; MICE; NEOVASCULARIZATION, PATHOLOGIC; VACCINES, DNA; XENOPUS LAEVIS;

EID: 77957278394     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01473.x     Document Type: Article

References (38)

1. Rosenberg SA. Progress in human tumor immunology and immunotherapy. Nature 2001; 411: 380-4.
2. Marincola FM, Jaffe EM, Hicklin DJ, Ferrone S. Escape of human solid tumors from T cell recognition: molecular mechanisms and functional significance. Adv Immunol 2000; 74: 181-273.
3. Bergman PJ, McKnight J, Novosad A et al. Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial. Clin Cancer Res 2003; 9: 1284-90.
4. Srinivasan R, Wolchok JD. Tumor antigens for cancer immunotherapy: therapeutic potential of xenogeneic DNA vaccines. J Transl Med 2004; 2: 12.
5. Pupa SM, Iezzi M, Di Carlo E et al. Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination. Cancer Res 2005; 65: 1071-8.
6. Neal ZC, Bates MK, Albertini MR, Herweijer H. Hydrodynamic limb vein delivery of a xenogeneic DNA cancer vaccine effectively induces antitumor immunity. Mol Ther 2007; 15: 422-30.
7. Ciesielski MJ, Apfel L, Barone TA, Castro CA, Weiss TC, Fenstermaker RA. Antitumor effects of a xenogeneic survivin bone marrow derived dendritic cell vaccine against murine GL261 gliomas. Cancer Immunol Immunother 2006; 55: 1491-503.
8. Gallo P, Dharmapuri S, Nuzzo M et al. Xenogeneic immunization in mice using HER2 DNA delivered by an adenoviral vector. Int J Cancer 2005; 113: 67-77.
9. Palomba ML, Roberts WK, Dao T et al. CD8+ T-cell-dependent immunity following xenogeneic DNA immunization against CD20 in a tumor challenge model of B-cell lymphoma. Clin Cancer Res 2005; 11: 370-9.
10. Wei YQ, Wang QR, Zhao X et al. Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine. Nat Med 2000; 6: 1160-6.
11. Liu JY, Wei YQ, Yang L et al. Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2. Blood 2003; 102: 1815-23.
12. He QM, Wei YQ, Tian L et al. Inhibition of tumor growth with a vaccine based on xenogeneic homologous fibroblast growth factor receptor-1 in mice. J Biol Chem 2003; 278: 21831-6.
13. Wei YQ, Huang MJ, Yang L et al. Immunogene therapy of tumors with vaccine based on xenopus homologous vascular endothelial growth factor as a model antigen. Proc Natl Acad Sci USA 2001; 98: 11545-50.
14. Rafii S. Vaccination against tumor neovascularization: promise and reality. Cancer Cell 2002; 2: 429-31.
15. Sahin U, Tureci O, Schmitt H et al. Human neoplasms elicit multiple specific immune response in the autologous host. Proc Natl Acad Sci USA 1995; 92: 11810-3.
16. Krackhardt AM, Witzens M, Harig S et al. Identification of tumor-associated antigens in chronic lymphocytic leukemia by SEREX. Blood 2002; 100: 2123-31.
17. Jäger D, Stockert E, Güre AO et al. Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library. Cancer Res 2001; 61: 2055-61.
18. Yang H, Wang C, Wang R et al. Characterization of the novel gene for rat testicular antigen protein 2 by cross-reactive serological analysis of recombinant cDNA. J Biosci Bioeng 2009; 107: 589-95.
19. Wang CT, Zhang P, Wang YS et al. RNA interference against Biot2, a novel mouse testis-specific gene, inhibits the growth of tumor cells. Cell Mol Biol Lett 2009; 14: 363-76.
20. Quenby S, Brazeau C, Drakeley A, Lewis-Jones DI, Vince G. Oncogene and tumour suppressor gene products during trophoblast differentiation in the first trimester. Mol Hum Reprod 1998; 45: 477-81.
21. Murray MJ, Lessey BA. Embryo implantation and tumor metastasis: common pathways of invasion and angiogensis. Semin Reprod Endocrinol 1999; 17: 275-90.
22. Tetens F, Kliem A, Tscheudschilsuren G, Navarrete Santos A, Fischer B. Expression of proto-oncogenes inbovine prei-implantation blastocysts. Anat Embryol (Berl) 2000; 201: 349-55.
23. Growe DL, Parsa B, Sinha UK. Relationships between stem cells and cancer stem cells. Histol Histopathol 2004; 19: 505-9.
24. Marin V, Kaplanski G, Gres S, Farnarier C, Bongrand P. Endothelial cell culture: protocol to obtain and cultivate human umbilical endothelial cells. J Immunol Methods 2001; 254: 183-90.
25. Sparmann A, Bar-Sagi D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 2004; 6: 447-58.
26. Roberts WG, Whalen PM, Soderstrom E et al. Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673, 451. Cancer Res 2005; 65: 957-66.
27. Gurunathan S, Klinman DM, Seder RA. DNA vaccines: immunology, application, and optimization. Annu Rev Immunol 2000; 18: 927-74.
28. Line A, Slucka Z, Stengrevics A, Silina K, Li G, Rees RC. Characterisation of tumour-associated antigens in colon cancer. Cancer Immunol Immunother 2002; 51: 574-82.
29. Fukui M, Ueno K, Suehiro Y, Hamanaka Y, Imai K, Hinoda Y. Anti-tumor activity of dendritic cells transfected with mRNA for receptor for hyaluronan-mediated motility is mediated by CD4+ T cells. Cancer Immunol Immunother 2006; 55: 538-46.
30. Lokeshwar VB, Selzer MG. Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel, and vein-derived human endothelial cells. J Biol Chem 2000; 275: 27641-9.
31. Hardwick C, Hoare K, Owens R et al. Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J Cell Biol 1992; 117: 1343-50.
32. Turley EA. Hyaluronan and cell locomotion. Cancer Metastasis Rev 1992; 11: 21-30.
33. Hall CL, Yang B, Yang X et al. Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation. Cell 1995; 82: 19-28.
34. Rein DT, Roehrig K, Schondorf T et al. Expression of the hyaluronan receptor RHAMM in endometrial carcinomas suggests a role in tumour progression and metastasis. J Cancer Res Clin Oncol 2003; 129: 161-4.
35. Greiner J, Ringhoffer M, Taniguchi M et al. Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia. Exp Hematol 2002; 30: 1029-35.
36. Savani RC, Cao G, Pooler PM, Zaman A, Zhou Z, DeLisser HM. Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis. J Biol Chem 2001; 276: 36770-8.
37. Hofmann M, Fieber C, Assmann V et al. Identification of IHABP, a 95kDa intracellular hyaluronate binding protein. J Cell Sci 1998; 111: 1673-84.
38. Groen AC, Cameron LA, Coughlin M, Miyamoto DT, Mitchison TJ, Ohi R. XRHAMM functions in ran-dependent microtubule nucleation and pole formation during anastral spindle assembly. Curr Biol 2004; 14: 1801-11.